HomePage 4 17 26

The 2020 Cochrane Review — medicine's gold standard for clinical research — analyzed 27 studies and more than 10,000 participants. Its conclusion: people who attend Alcoholics Anonymous are 20–60% more likely to achieve one year of abstinence than those given evidence-based therapies — the primary clinical approach used in 95% of modern addiction treatment programs — and no study found AA performing worse.

Stanford addiction scientist Dr. Keith Humphreys — White House drug policy advisor under Bush and Obama, and lead of the Stanford-Lancet Commission on the Opioid Crisis — dismissed 12-Step recovery as “utterly ridiculous” early in his career. Humphreys co-led the 2020 Cochrane Review that changed his mind. Listen to him explain the findings.

Listen: Dr. Humphreys on the Cochrane Review (8 min) Source

The findings were unambiguous.

Nothing Has Changed

Six years after the Cochrane Review, 95% of the $42 billion addiction treatment industry still delivers evidence-based therapies as the primary clinical path. The Cochrane findings are publicly available — the field’s response has been silence.

Before 12-Step Facilitation There Was a 12-Step Treatment Model That Produced a Documented 93% Recovery Success Rate

The original 1930s and 1940s Ohio Model embedded 12-Step members directly into clinical treatment through coordinated physician oversight and intensive altruistic peer engagement during detox and rehab.

The Ohio Model

Free from the distractions of home and work — recovered 12-Step members worked one-on-one with each patient as a means of performing their own altruistic 12th Step work, forming deep bonds and completing the bulk of the patient’s critical transformative step work before discharge.

It wasn’t a therapy. It was a coordinated arrangement of physicians, sponsors, patients, and daily practice — a loose system, but a working one, that produced recovery outcomes nothing since has come close to matching.

When the patient left, they didn’t just leave clean and sober. They left with a familiar community waiting for them — and a place in it; people who shared the same role, purpose, function in their community — paying forward what they had been given — by working with incoming patients.

Dr. Bob Smith — the physician who pioneered it — died suddenly in 1950, before he could codify what he had built. The systems that might have scaled it — data capture, coordinated care platforms, and learning systems — were half a century away.

It didn’t fail. It was never engineered.

Addiction Treatment Today

Six Stages of Care. Six Points of Failure. Zero Accountability.

Each year, millions of Americans enter detox/rehab seeking lasting recovery, then leave without a system designed to carry responsibility for what follows.

As each stage ends, continuity breaks down, accountability fragments, and individuals are left to manage recovery alone.

Most relapse in their first year.

What follows is not a simple treatment industry.

It is a constellation of industries that have grown up around millions of addicted patients over the past several decades.

The people inside these industries are largely working hard and trying to help. The incentives that tie them together do not.

The financial structure rewards admissions, billings, and returning patients — not lifelong recovery.

The industry calls it a continuum of care. It is not. Here’s what that landscape actually looks like.

The Patient's Journey: Day 0 to Year 50

1

Detox

Day 0–10: Visitors No Longer Arrive.

Day 0–10 is the most psychologically receptive window of a patient’s life. The defenses are down. The mind is briefly open.

The physician no longer sits bedside — no longer deploys the White Coat Effect to open the patient to receiving recovered visitors.

Local 12-Step members no longer arrive to walk the patient through the critical transformative 12-Step process before discharge.

Patients no longer leave set on a 12-Step trajectory, a familiar recovered community waiting at local meetings, or a standing invitation to return and walk incoming patients through the same process, completing the loop by performing their critical altruistic 12th Step work.

The window closes with the patient on the wrong path — evidence-based therapies — and a host of misunderstandings that stay with them for life.

“Particularly was it imperative to work with others as he had worked with me.” Alcoholics Anonymous, page 14

2

Post-Acute Detox

Day 10–30: The Neurological Reboot

Acute detox ends. Reimbursement steps down sharply. So does clinical oversight. The body is detoxed. But the brain, after years of chemical disruption, begins its own form of detox — a known neurological rebooting process called Post-Acute Detox. For twenty days dopamine collapses, sleep breaks, panic rises.

The neurological process is known. Vitals and biological signals are measurable with standard clinical instrumentation. None are used during the post-acute window.

Known symptoms. Predictable timeline. No one monitoring, intervening, or mitigating the collapse.

3

Misdiagnosis

Days 15–25: The Pivot

Because post-acute detox goes unmeasured, its symptoms get classified as something else entirely.

It’s Day 22. The patient’s brain is rebooting. Their mood is swinging violently. Nothing is being measured. The doctor — on a Zoom call, not required to be onsite — has no data to work with.

The doctor diagnoses the patient with a psychiatric disorder: anxiety, bipolar, treatment-resistant depression — sometimes all three. The doctor writes a prescription. To a patient at the most vulnerable point of their adult life, a doctor in a white coat is institutional authority. The patient takes the prescription. The misdiagnosis enters the medical record and follows them for the rest of their life.

The alternative — working steps, writing inventories, making amends, helping others altruistically — does not match how Americans expect medicine to work. Americans expect a professional to fix the problem. The pharmaceutical/therapy-sessions path matches that expectation. The make-amends/altruistic/12-Step path does not — and so the patient’s addiction goes untreated.

The patient enters with addiction. A doctor diagnoses without data. The misinformed patient leaves with a psychiatric label — headed down the wrong path for life.

4

Sober Living

Day 30–90: Six Strangers in a House.

The patient is discharged into a sober living home. So are five other people they’ve never met.

Most of them are on prescribed medications. Roughly two-thirds of substance use treatment patients receive a co-occurring psychiatric diagnosis and are medicated for it. By the time these patients arrive at sober living, most have prescriptions — many from misdiagnoses made during their post-acute window.

In most states, no clinical license is required to operate a sober living home. No clinician works at the house. No clinical protocol governs daily life. Nothing is measured. Residents are housed together because beds are available, not because their clinical profiles match.

A peer culture forms by accident. It tends to organize around the lowest common denominator in the room — the loudest voice, the resident closest to relapse. Whatever recovery the patient brought through the door is now exposed to the chemistry of the strangers they happen to now be living with.

No clinician lives here. No protocol governs the house.

5

Discharge

Months 3–12: No Feedback Loop

Every industry that works at scale runs on measurement. Outcomes get tracked. Variances get analyzed. Processes improve. The next cohort benefits from what the previous cohort revealed. The addiction treatment industry runs on none of this.

By month three, the patient has been fully discharged. Nothing about their trajectory has ever been tracked: step work, meeting attendance, community engagement. No one knows whether the medications prescribed during post-acute detox are still necessary, or being taken.

The industry has no economic reason to track any of it. Revenue comes from admissions, not outcomes. The amount of revenue generated does not change based on whether the patient stays sober. A relapse months after discharge is invisible to the system.

The only people measuring this industry come from outside. Academic researchers — Keith Humphreys at Stanford, the Cochrane team, the NIDA-funded investigators — periodically arrive, capture data, publish findings, and leave. Their reports do not become protocol changes. They become conference talks and journal citations. The industry does not act on them.

A forty-billion-dollar industry that has not measurably improved its long-term recovery rates for decades.

6

Lifelong Recovery

Years 1–50+: No One Is Assigned to This

Rock-solid, lifelong recovery requires a fundamental shift in thinking: from focusing on oneself to helping others recover.

The Ohio Model ensured that shift. Patients processed their past through structured step work, then returned to guide incoming patients.

Modern treatment tells the patient to be altruistic, hands them a meeting schedule, and hopes for the best. They are not invited back for intensive altruistic step work.

That missing altruistic role leaves a void — and waiting to fill it are pharmaceutical, psychotherapy, wellness, and self-help industries built to manage former patients.

These industries generate billions managing symptoms, but they do not restore the missing altruistic role or reliably treat the addiction at its core.

So, if the patient makes it this far, they are left to navigate decades of life with no permanently assigned altruistic role.

7

The addiction treatment industry counts treatment. It has never measured whether treatment works.

A volunteer fellowship with no budget and no database did something the $42 billion addiction treatment industry has never done: it kept score.

Since its inception, Alcoholics Anonymous has estimated its worldwide membership — counting groups, meetings, and members as best it could. The numbers are rough. AA says so itself. But it is the only multi-decade record of recovery participation that exists anywhere.

By the early 1990s, that curve stopped compounding. It plateaued near two million and never climbed again. AA does not claim to know exactly why. Neither do we.

The real indictment is what sits on the other side of the chart: nothing.

The industry has admissions data, discharge data, facility counts, and population surveys. Every federal dataset measures the same thing — activity. How many patients were admitted. How many beds were filled. How many services were billed.

Not one of them measures whether the patient got well.

A volunteer fellowship tracked its own outcomes for ninety years. A forty-two-billion-dollar industry never built the ledger to track its own.

The original Ohio Model depended on culture, conviction, and proximity. It worked because physicians, recovered alcoholics, and patients were connected inside a shared, interpersonal recovery process. But AA’s founders never converted their methods into a scalable operating system.

As the Minnesota Model expanded and healthcare became more institutionalized, TSF was later validated as effective — yet never fully systematized into disciplined operating protocols. What should have become a governed clinical process became a recommendation, leaving no enforceable standard for execution, measurement, or replication.

8

The People Were Never the Problem

The doctors, nurses, and counselors working in addiction treatment are not the cause of the failures described on this page.

They treat patients using the methods taught in medical schools, nursing programs, and in addiction-counseling certifications.

These professionals enter the field to help people. The system they were trained to operate is the problem — not the people operating it.

A broken system cannot be fixed one professional at a time. The entire system has to be rebuilt.

The Rellennium Solution

One Operating System for Lifelong Recovery

Rellennium is restoring the Ohio Model. Our restoration has two parts: a doctor-led detox/rehab facility and a platform of nine purpose-built systems. Together they orchestrate every step of treatment and lifelong recovery, ensuring the right thing happens at the right time, consistently. The first facility is our pilot site — where both the clinical model and the nine-system platform deploy together for the first time, prove out, and prepare to scale. Our North Star is simple: a national recovery rate that rises and holds.

Engineered Behavioral Healthcare

What’s missing is not the method, but the systems needed to deliver effective TSF. Today, TSF is not integrated, measured, or actively coordinated within treatment. It operates outside the clinical framework, without accountability or consistency.

Rellennium has engineered a physician-led, abstinence-based, data driven full-continuum addiction treatment model that provides one continuous treatment path from acute detox through lifelong recovery. Altruism, once the heart of the original model, is the engine of this new one; the altruistic cycle, where today’s patients become tomorrow’s guides will finally be fully restored.

Where Dr. Bob had instinct, we have instrumentation. Where the original lived in the people who practiced it, we encode it as one system. Recovered members at the bedside, systems and physicians coordinating their work, structured 12-Step step protocols, measurable engagement, status dashboards; all of it using captured, anonymized longitudinal data.

LMS: Structured 12-Step Execution

The Learning Management System resurrects the Cleveland sponsorship method developed by Clarence Snyder— and converts it into a structured, repeatable behavioral protocol delivered through modern learning architecture.

A ten-hour video series guides each user through a 170-page fill-in-the-blanks workbook and more than 400 quiz questions walk them through the exact sequence that ensures the patient rapidly processes their entire past. Gamification keeps the experience engaging — milestone badges, leaderboards, and the biggest reward of all: new systems unlock as rewards as they progress through each step. Behind the experience, the LMS adapts pacing, surfaces remediation, and feeds the data backbone.

Everyone on the platform completes the LMS and becomes 12-Step certified: doctors, nurses, visitors, sponsors, HomeStay hosts, clergy, local mental health professionals, and family members. No mixed messages. No conflicting philosophies. The entire ecosystem speaks the same language and works from the same proven template.

Echo: Orchestrated 12-Step Immersion

The Echo Mobile App is the orchestration layer that turns the Ohio Model from a 1940s practice into a 21st-century clinical workflow — the layer the original model never had.

With a single tap from the physician, demographically-matched and locally-certified 12-Step members receive invitations on their phones, claim time slots, and arrive at the bedside to begin the relational work that establishes the foundation of lifelong recovery. Every visit is time-stamped, biometrically tied, and anomalously fed into a system that learns from every patient and every site — making the same matching engine extensible to every recovery context Rellennium will eventually serve.

Our HomeStay Network

When the doctor determines the patient’s post-acute detox phase is stable, the doctor activates the Homestay App on the patient’s dashboard. The patient can then browse doctor-vetted homes owned by local, recovered 12-Step members and choose an environment that fits their circumstances and comfort level. Unlike traditional sober living—where five or six vulnerable patients share a house with minimal oversight—each Homestay hosts only one resident. Patients, now residents, complete any remaining 12-Step work with their sponsor as they integrate into their local recovery community.

Whether selecting oceanfront comfort in Laguna Beach or a modest home inland, every resident receives the same support. Homestay delivers safety, structure, economic empowerment for hosts, and a clear path from early recovery into lifelong altruistic service.

Performance Tracking and Reporting

Performance Tracking is the system that makes Rellennium self-improving. Real-time dashboards give physicians, franchise operators, and the network the alerts, metrics, and recommendations they need to guide day-to-day care and surface struggling patients early. Twice each month, Rellennium’s medical team reviews AI-surfaced patterns, validates them against the underlying anonymized dataset, and votes on which protocol improvements roll out network-wide. Best practices no longer wait decades to spread through conferences. They are validated by physicians, deployed across the franchise instantly, and refined again with the next cohort of patients. The result is a self-correcting clinical operating system that gets measurably better with every patient.

Moneyball Medicine Today’s treatment industry measures what’s billable. Rellennium measures what matters. Detox facility success rates become transparent. Physician effectiveness is quantified. HomeStay environments are ranked by resident outcomes. Sponsor compatibility is scored. Visitor impact is tracked against patient progress. Standard reports run automatically, establishing the industry’s first real recovery metrics. When life and death are at stake, addiction treatment should be held to higher performance standards than professional sports.

Privacy by Design, Asset by Compounding

Rellennium runs on a two-vault data architecture. Protected health information lives inside a HIPAA vault — physically isolated, encrypted, and never accessed by AI.

A second vault stores anonymized longitudinal behavioral data — biometrics, behaviors, step-work, recovery outcomes — captured under nicknames rather than identities. This is the only vault the AI touches. Privacy isn’t a policy at Rellennium. It’s infrastructure. Over time, the second vault becomes the most valuable asset in the company: the largest longitudinal record of human behavioral transformation ever assembled — irreplaceable because longitudinal data compounds, defensible because privacy is architectural, and applicable far beyond addiction in the AI era.

Two-Vault Architecture — Privacy by Design All Protected Health Information is locked inside a dedicated HIPAA vault — physically isolated and never accessed by AI. A second vault stores operational data under anonymized nicknames rather than identities. This is the only vault the AI touches. By separating identity from outcome data at the architectural level, Rellennium protects patient confidentiality while enabling thousands of daily decisions to be guided with precision and consistency. This isn’t a policy — it’s infrastructure. Privacy is built into the system, not bolted on.

AI-Driven Improvement The AI trains on the anonymous vault — pattern-matching across thousands of recovery trajectories to surface insights no human could detect. Which visitor pairings produce breakthrough moments. Which intervention timing correlates with sustained recovery. Which biomarker shifts predict relapse weeks before it happens. Physicians query the system and receive probabilities grounded in measurable data, not opinions. Every recommendation is traceable back to the underlying anonymous dataset — no black box, no guesswork. The AI learns continuously, and every patient’s journey refines the next patient’s path.

The Compounding Data Asset Every patient who enters the system deepens the dataset. With 1,000 patients tracked longitudinally, the data is interesting. With 10,000, statistically significant patterns emerge. With 100,000, Rellennium holds the definitive dataset on human behavioral transformation — applicable far beyond addiction to habit formation, mental health treatment, and human performance optimization. The dataset becomes irreplaceable because longitudinal data compounds — you cannot recreate five years of continuous tracking overnight. This isn’t a treatment program that generates data. It’s a data asset that transforms lives.

The Franchise Model

Rellennium scales through a physician-led, turnkey franchise model where financial returns are mathematically tied to recovery outcomes. Every franchise owned and operated by a physician who sits bedside, oversees treatment, and drives the local recovery ecosystem. The model aligns every stakeholder — physician/franchise owner, staff, Homestay host, and corporate — around a single metric: long-term recovery rates. When patients recover, everyone prospers. When they don’t, the data shows why and the system drives ongoing process improvement. This isn’t a network of facilities. It’s an evolving system designed to continuously get better with every patient, at every location.

Physician Ownership & Equity Alignment Each franchise follows a precise equity structure. Rellennium Corporate holds 61% to maintain quality standards and model integrity. The physician-owner invests 30%, vesting over five years to ensure long-term commitment. The remaining 9% flows to key staff — nurses, counselors, operations managers — at the physician/owner’s discretion. Profit distribution reinforces alignment: the physician-owner controls 45% of annual profits, employees collectively receive 30% scaled by individual performance, and corporate takes 25%. Franchises that achieve top-quartile recovery rates accumulate up to 10% additional ownership over time, reducing corporate’s share from 25% to 15%. A physician operating a $10 million facility can build $15–20 million in career wealth — but only by sustaining superior outcomes.

Economic Incentives That Drive Outcomes Excellence is rewarded at every level. Staff earn profit-sharing based on care quality and patient outcomes, not seniority. Professionals are compensated based on the outcomes they produce — not allowed to blame the patient when relapse occurs. HomeStay hosts have economic agency — earning real income for providing structured rehabilitation support. Visitors and sponsors are tracked by effectiveness, prizes are rewarded locally. Upon retirement, physicians earn 3% of profits from every franchise they help launch, creating a mentorship economy where experienced physicians actively recruit and develop successors. The incentive cascade ensures that every person in the ecosystem benefits when recovery rates rise — and every person is accountable, and retrained, when they don’t.

Scalability Through Standardization Every franchise delivers an identical structured journey — the same medical protocols, the same LMS training, the same Echo App coordination, the same data capture, the same metrics. A patient entering detox in Irvine receives the exact same care as someone in Malibu or downtown Los Angeles. When one facility discovers a breakthrough approach, the data surfaces it, corporate validates it, and the improvement deploys across every location in the network. Wins anywhere become wins everywhere. Well-run detox facilities typically achieve positive cash flow within months. Each franchise becomes self-sustaining within its first year — clinical excellence and financial sustainability proving inseparable.

The Replacement Strategy Rellennium will not argue with the treatment industry about why current success rates are unacceptable. It will simply deliver superior recovery outcomes and let results speak. As independent auditors validate what the data already shows, capital will follow results. This data-driven model won’t need to compete with today’s facilities. It will replace them — market by market, through the simple power of proven, measurable, continuously improving outcomes.

Market Opportunity

Rellennium enters through the highest-leverage point in the addiction treatment continuum: inpatient detox — the first 30–60 days, when long-term recovery trajectories are set. It’s also where the market is most broken. Demand is rising, outcomes are declining, and no existing operator owns the full continuum or measures its own performance. That contradiction creates the opening. A well-run detox/rehab facility generates 20–25% EBITDA margins and can reach profitability inside the first year — strong unit economics in a large, fragmented industry ripe for consolidation. Our wedge is designed as a learning system, not an endpoint — generating the proof, the revenue, the clinical credibility, and the dataset that powers every phase of recovery that follows. Industries this fragmented eventually consolidate around whoever gets the fundamentals right. We believe that will be the operator that measures what actually works and holds itself accountable for the results — and we’re building Rellennium to be that operator.

$6B — U.S. Detox/Rehab & Aftercare The detox and rehab franchise is designed as a learning system, not an endpoint. By operating residential care first, Rellennium generates the data, workflows, and AI-guided insights needed to engineer effective treatment at scale.

$42B — U.S. Broader Addiction Treatment The same systems that power residential care will naturally extend into outpatient addiction treatment. Patients and families who recover outside inpatient settings gain access to structured tools, certified sponsor matching, and guided recovery pathways — supported by the same continuous improvement model. As the platform’s dataset grows and outcomes are validated, Rellennium expands from residential care into the full U.S. addiction treatment and aftercare market.

$300B+ — U.S. Behavioral Health & Human Connection The behavioral health crisis extends far beyond addiction. Loneliness, depression, anxiety, and loss of purpose are accelerating — driven by digital isolation, AI-driven job displacement, and the breakdown of community. Rellennium’s platform infrastructure — the matching algorithms, the LMS, the community tools, the data systems — was designed to be repurposed. The same system that orchestrates addiction recovery can deliver rapid psychological clearing and guide people into real-world altruistic roles that restore purpose, accountability, and belonging. Addiction is the initial wedge. The platform’s architecture addresses the full spectrum of human disconnection — representing a $300B+ U.S. opportunity and over $1T globally.

The U365 Vision

Addiction is the first application — not the last. The platform Rellennium is building for addiction recovery was designed from day one to be repurposed. The same matching algorithms, the same LMS architecture, the same community tools, the same data systems that orchestrate addiction recovery can address the broader crisis of human disconnection that is accelerating across every demographic.

The Deeper Crisis In 2022, the U.S. Surgeon General declared loneliness a public health epidemic rivaling smoking in its mortality impact. Depression and anxiety surge across every age group. In the coming decade, artificial intelligence will displace millions from traditional employment — threatening the foundations of identity and purpose that industrial society constructed. Hundreds of millions already suffer what anthropologists call the evolutionary mismatch: biologically wired for tribal interdependence but living in profound disconnection, digitally “connected” yet painfully isolated. Addiction, loneliness, purposelessness, and family breakdown are not separate crises. They are symptoms of one catastrophe — the destruction of human belonging.

One Platform, Three Expanding Circles Rellennium does not build three platforms. It builds one system powerful enough to serve three expanding circles of need — each phase funding and validating the next.

Phase One establishes the core infrastructure through addiction treatment. The R365 Platform perfects the matching algorithms, the LMS, the data capture, the community tools, and the continuous improvement engine — all validated against the hardest possible use case. If it works for addiction, it works for everything.

Phase Two adapts the platform for every 12-Step fellowship worldwide. Over 200 fellowships exist — Al-Anon for families, Gamblers Anonymous, Overeaters Anonymous, and dozens more. Each receives fellowship-specific modules while gaining the same LMS, connection tools, and outcome tracking that power the addiction model.

Phase Three unleashes the infrastructure for humanity itself. The isolated teenager. The displaced worker. The grieving widow. The purposeless retiree. The same system that produces recovery from addiction produces recovery from disconnection. The algorithms do not distinguish whether they are matching sponsors with alcoholics or mentors with the isolated. They connect humans who need each other — calibrating geography, experience, and readiness to create meaningful matches.

The Regenerative Model The U365 Platform offers something most mental health solutions ignore: systematic psychological clearing combined with lifelong community integration. Users do not simply learn coping strategies. They process their entire past through structured LMS work, then activate into lifelong altruistic service through the Echo App and community tools. Crisis becomes purpose. Isolation becomes invitation. Those recovering from any life rupture become guides for the next wave. This is not crisis intervention. It is the systematic restoration of human interdependence — scaled through technology, sustained through service, and measured through anonymous data that drives continuous improvement.

Where the Puck Is Going The same AI systems Rellennium builds to orchestrate addiction recovery will eventually possess something unprecedented — a living, longitudinal dataset on human behavioral transformation. As AI advances, it will need frameworks and tools to understand the human condition: the ego, self-centeredness, loneliness, disconnection. Rellennium’s platform provides both the data and the infrastructure for AI to guide human connection rather than replace it. The company is not just building a treatment platform. It is building the social architecture that a post-labor, AI-driven world will require.

The Team

Rellennium is built by two systems engineers who spent their careers making broken operations measurable and repeatable, and who know recovery from the inside.

David Boland — Founder & CEO. 30 years of continuous sobriety and decades inside 12-Step recovery. David personally ran the protocol Rellennium standardizes, taking dozens of people one-on-one through the full Big Book sponsorship process that most members never experience. His profession is systems: an MS in Technology Systems and Information Security, a BS in Business in MIS, decades of manufacturing, warehousing, and logistics turnarounds, and continuous process improvement. For over a decade he studied why the original physician-led model worked and why it was dismantled. He took the documented 1940s Ohio Model, re-engineered it into a specification, built the Learning Management System, and designed the platform architecture — including the two-vault data design his information-security training directly informs.

Patricia Boland — Co-Founder. Systems engineer. MS in Systems Engineering, BS in Industrial Engineering, Lean Six Sigma Black Belt. Twenty-plus years in manufacturing and process engineering at companies including 3M, leading continuous-improvement programs that protected tens of millions in contracts. Patricia brings the discipline that makes the model buildable, replicable, and sustainable across a franchise network.

Dr. Jordan Young — Advisor, Clinical. Internal Medicine, with hospital and program-director experience. Dr. Young supports the clinical model and is helping recruit the co-founder physician who will lead the pilot facility.

Brian Stringfellow – Data Security Advisor. A 25-year data-security professional advising Rellennium’s two-vault data architecture and supporting the platform build until the CTO is hired.

The Critical Hires. The clinical model and the systems are built. The two hires that turn them on — the co-founder physician who leads care at the pilot facility, and the CTO who owns the platform build — are the first and most deliberate use of capital. Both are already de-risked: a physician advisor is helping recruit the lead doctor, and a 25-year data-security expert is guiding the architecture in the interim.